Showing results (101-110 of 144) with videos related to

Sort By:
Pageof 15
Molecular Genetics and Metabolism|November 11, 2018
The effect of enzyme replacement therapy on clinical outcomes in female patients with Fabry disease - A systematic literature review by a European panel of expertsDominique P Germain, Michael Arad, Alessandro Burlina, et al.
American Journal of Medical Genetics. Part A|June 20, 2017
Psychiatric and cognitive characteristics of individuals with Danon disease (LAMP2 gene mutation)Maya Yardeni, Omri Weisman, Hanna Mandel, et al.
Clinical Transplantation|October 10, 2017
Early aspirin initiation following heart transplantation is associated with reduced risk of allograft vasculopathy during long-term follow-upYael Peled, Jacob Lavee, Eugenia Raichlin, et al.
Circulation|November 4, 2005
Gene mutations in apical hypertrophic cardiomyopathyMichael Arad, Manual Penas-Lado, Lorenzo Monserrat, et al.
Stem Cells and Development|May 26, 2016
Epoxyeicosatrienoic Acids Regulate Adipocyte Differentiation of Mouse 3T3 Cells, Via PGC-1α Activation, Which Is Required for HO-1 Expression and Increased Mitochondrial FunctionMaayan Waldman, Lars Bellner, Luca Vanella, et al.
Clinical Transplantation|July 29, 2017
Risk of early, intermediate, and late rejection following heart transplantation: Trends over the past 25 years and relation to changes in medical management. Tertiary center experience: The Sheba Heart Transplantation RegistryMoshe Katz, Dov Freimark, Eugenia Raichlin, et al.
Heart Rhythm|September 18, 2017
CRISPR correction of the PRKAG2 gene mutation in the patient's induced pluripotent stem cell-derived cardiomyocytes eliminates electrophysiological and structural abnormalitiesRonen Ben Jehuda, Binyamin Eisen, Yuval Shemer, et al.
International Journal of Cardiology|July 16, 2023
Clinical features of pediatric Danon disease and the importance of early diagnosisLeila Gandaeva, Natalia Sonicheva-Paterson, William J McKenna, et al.
The New England Journal of Medicine|January 28, 2005
Glycogen storage diseases presenting as hypertrophic cardiomyopathyMichael Arad, Barry J Maron, Joshua M Gorham, et al.
JAMA|March 26, 2009
Clinical outcome and phenotypic expression in LAMP2 cardiomyopathyBarry J Maron, William C Roberts, Michael Arad, et al.
Pageof 15